414 related articles for article (PubMed ID: 29551015)
1. Anti-IgE therapy for allergic bronchopulmonary aspergillosis in people with cystic fibrosis.
Jat KR; Walia DK; Khairwa A
Cochrane Database Syst Rev; 2018 Mar; 3(3):CD010288. PubMed ID: 29551015
[TBL] [Abstract][Full Text] [Related]
2. Anti-IgE therapy for allergic bronchopulmonary aspergillosis in people with cystic fibrosis.
Jat KR; Walia DK; Khairwa A
Cochrane Database Syst Rev; 2015 Nov; (11):CD010288. PubMed ID: 26545165
[TBL] [Abstract][Full Text] [Related]
3. Anti-IgE therapy for allergic bronchopulmonary aspergillosis in people with cystic fibrosis.
Jat KR; Walia DK; Khairwa A
Cochrane Database Syst Rev; 2013 Sep; (9):CD010288. PubMed ID: 24043500
[TBL] [Abstract][Full Text] [Related]
4. Anti-IgE therapy for allergic bronchopulmonary aspergillosis in people with cystic fibrosis.
Jat KR; Walia DK; Khairwa A
Cochrane Database Syst Rev; 2021 Sep; 9(9):CD010288. PubMed ID: 34550603
[TBL] [Abstract][Full Text] [Related]
5. Azoles for allergic bronchopulmonary aspergillosis associated with asthma.
Wark PA; Gibson PG; Wilson AJ
Cochrane Database Syst Rev; 2004; 2004(3):CD001108. PubMed ID: 15266440
[TBL] [Abstract][Full Text] [Related]
6. Omalizumab treatment for allergic bronchopulmonary aspergillosis in young patients with cystic fibrosis.
Perisson C; Destruys L; Grenet D; Bassinet L; Derelle J; Sermet-Gaudelus I; Thumerelle C; Prevotat A; Rosner V; Clement A; Corvol H
Respir Med; 2017 Dec; 133():12-15. PubMed ID: 29173443
[TBL] [Abstract][Full Text] [Related]
7. Antifungal therapies for allergic bronchopulmonary aspergillosis in people with cystic fibrosis.
Francis NZ; Southern KW
Cochrane Database Syst Rev; 2022 Sep; 9(9):CD002204. PubMed ID: 36053129
[TBL] [Abstract][Full Text] [Related]
8. Azoles for allergic bronchopulmonary aspergillosis associated with asthma.
Wark PA; Gibson PG; Wilson AJ
Cochrane Database Syst Rev; 2003; (3):CD001108. PubMed ID: 12917898
[TBL] [Abstract][Full Text] [Related]
9. Case series of omalizumab for allergic bronchopulmonary aspergillosis in cystic fibrosis patients.
Nové-Josserand R; Grard S; Auzou L; Reix P; Murris-Espin M; Brémont F; Mammar B; Mely L; Hubert D; Durieu I; Burgel PR
Pediatr Pulmonol; 2017 Feb; 52(2):190-197. PubMed ID: 27717223
[TBL] [Abstract][Full Text] [Related]
10. Omalizumab for asthma in adults and children.
Normansell R; Walker S; Milan SJ; Walters EH; Nair P
Cochrane Database Syst Rev; 2014 Jan; 2014(1):CD003559. PubMed ID: 24414989
[TBL] [Abstract][Full Text] [Related]
11. Omalizumab therapy for allergic bronchopulmonary aspergillosis in children with cystic fibrosis: a synthesis of published evidence.
Tanou K; Zintzaras E; Kaditis AG
Pediatr Pulmonol; 2014 May; 49(5):503-7. PubMed ID: 24167019
[TBL] [Abstract][Full Text] [Related]
12. Antifungal therapies for allergic bronchopulmonary aspergillosis in people with cystic fibrosis.
Elphick HE; Southern KW
Cochrane Database Syst Rev; 2012 Jun; (6):CD002204. PubMed ID: 22696329
[TBL] [Abstract][Full Text] [Related]
13. Antifungal therapies for allergic bronchopulmonary aspergillosis in people with cystic fibrosis.
Elphick HE; Southern KW
Cochrane Database Syst Rev; 2016 Nov; 11(11):CD002204. PubMed ID: 27820955
[TBL] [Abstract][Full Text] [Related]
14. Antifungal therapies for allergic bronchopulmonary aspergillosis in people with cystic fibrosis.
Elphick HE; Southern KW
Cochrane Database Syst Rev; 2014 Nov; (11):CD002204. PubMed ID: 25431975
[TBL] [Abstract][Full Text] [Related]
15. Anti IgE antibody as treatment of allergic bronchopulmonary aspergillosis in a patient with cystic fibrosis.
Zicari AM; Celani C; De Castro G; Valerio De Biase R; Duse M
Eur Rev Med Pharmacol Sci; 2014 Jul; 18(13):1839-41. PubMed ID: 25010610
[TBL] [Abstract][Full Text] [Related]
16. Omalizumab in the management of steroid dependent allergic bronchopulmonary aspergillosis (ABPA) complicating cystic fibrosis.
Wong R; Wong M; Robinson PD; Fitzgerald DA
Paediatr Respir Rev; 2013 Mar; 14(1):22-4. PubMed ID: 23287795
[TBL] [Abstract][Full Text] [Related]
17. Antifungal therapies for allergic bronchopulmonary aspergillosis in people with cystic fibrosis.
Elphick H; Southern K
Cochrane Database Syst Rev; 2000; (4):CD002204. PubMed ID: 11034746
[TBL] [Abstract][Full Text] [Related]
18. Omalizumab: a new treatment option for allergic bronchopulmonary aspergillosis in patients with cystic fibrosis.
Lehmann S; Pfannenstiel C; Friedrichs F; Kröger K; Wagner N; Tenbrock K
Ther Adv Respir Dis; 2014 Oct; 8(5):141-9. PubMed ID: 25150265
[TBL] [Abstract][Full Text] [Related]
19. [Role of omalizumab in the management of allergic bronchopulmonary aspergillosis in patients with cystic fibrosis].
Delgado Pecellín I; Quintana Gallego E; Pedregal Solano C; Calero Acuña C
Med Clin (Barc); 2015 Feb; 144(4):190-1. PubMed ID: 25015245
[No Abstract] [Full Text] [Related]
20. Azoles for allergic bronchopulmonary aspergillosis associated with asthma.
Wark P; Wilson AW; Gibson PG
Cochrane Database Syst Rev; 2001; (4):CD001108. PubMed ID: 11687098
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
